Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 331

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 331
---
 to provide for an annual cash retainer for all non-employee directors, in addition to equity grants determined by the compensation committee and reimbursement for reasonable expenses incurred in connection with attending board and committee meetings. The board of New VIWO expects to review non-employee director compensation periodically to ensure that non-employee director compensation remains competitive such that New VIWO is able to recruit and retain qualified non-employee directors. The amount and form of such compensation has not yet been determined.

<div align='center'>202</div>

Audit Committee

A listed company of the Nasdaq must have an audit committee with a minimum of three independent directors who satisfy the independence requirements of Rule 10A-3. Upon the effectiveness of the Business Combination, New VIWO will establish an audit committee of the board of directors. Jrang Teen, Shuding Zeng, Zhengcai Liu will serve as members of New VIWO’s audit committee. New VIWO’s board of directors will determine that each of Jrang Teen, Shuding Zeng and Zhengcai Liu meet the independent director standard under Nasdaq listing standards and under Rule 10A-3(b)(1) of the Exchange Act. Zhengcai Liu will serve as the chairman of the audit committee.

Each member of the audit committee is financially literate and New VIWO’s board of directors has determined that each qualifies as an “audit committee financial expert” as defined in applicable SEC rules. New VIWO have adopted an audit committee charter, which details the principal functions of the audit committee, including:

| ● | appointing, compensating and overseeing New VIWO’s independent registered public accounting firm;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| ● | reviewing and approving the annual audit plan for the company and assisting board oversight of (1) the integrity of New VIWO’s financial statements, (2) New VIWO’s compliance with legal and regulatory requirements, (3) New VIWO’s independent registered public accounting firm’s qualifications and independence, and (4) the performance of New VIWO’s internal audit function and independent registered public accounting firm; the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by us; |
| ● | overseeing the integrity of New VIWO’s financial statements and New VIWO’s compliance with legal and regulatory requirements;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| ● | discussing the annual audited financial statements and unaudited quarterly financial statements with management and the independent registered public accounting firm;